Access cutting-edge autoimmune encephalitis treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access autoimmune encephalitis specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related autoimmune encephalitis treatment provided free
The purpose of this study is to assess the efficacy, safety, PK, and PD of satralizumab in participants with NMDAR and LGI1 encephalitis.
Sponsor: Hoffmann-La Roche
Check if you qualify for this autoimmune encephalitis clinical trial in Iowa City, IA
If you're searching for autoimmune encephalitis treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autoimmune encephalitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.